Effects of statins on oxidative stress

Biological Trace Element Research

Volumn 98, Issue 2, 2004, Pages 119-127

  Yilmaz, M Ilker ^a   Baykal, Y ^a   Kilic, M ^a   Sonmez, A ^a   Bulucu, F ^a   Aydin, A ^a   Sayal, A ^a   Kocar, I Hakki ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Copper; Glutathione peroxidase; Hypercholesterolemia; Iron; Malondialdehyde; Superoxide dismutase; Zinc

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; FLUINDOSTATIN; GLUTATHIONE PEROXIDASE; IRON; LIPID; MALONALDEHYDE; TRACE ELEMENT; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MALE; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; ERYTHROCYTES; FATTY ACIDS, MONOUNSATURATED; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERCHOLESTEROLEMIA; INDOLES; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TRACE ELEMENTS;

EID: 2342615455     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:98:2:119     Document Type: Article

References (34)

1. W. Palinski and S. Tsimikas, Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis, J. Am. Soc. Nephrol. 13(6), 1673-1681 (2002).
2. S. Wolfrum, K. S. Jensen, and J. K. Liao, Endothelium-dependent effects of statins, Arterioscler. Thromb. Vasc. Biol. 27, 729-736 (2003).
3. L. J. Ignarro, C. Napoli, and J. Loscalzo, Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview, Circ. Res. 90, 21-28 (2002).
4. A. M. Gotto, Jr, Statin therapy: where are we? where do we go next? Am. J. Cardiol. 87, 13B-18B (2001).
5. C. Guijarro, L. M. Blanco-Colio, M. Ortego, et al., 3-Hydroxy-3- methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture, Circ. Res. 83, 490-500 (1998).
6. L. Liu, P. Moesner, N. L. Kovach, et al., Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s), J. Biol. Chem. 274, 33,334-33,340 (1999).
7. F. M. Sacks, M. A. Pfeffer, L. A. Moye, et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators, N. Engl. J. Med. 335, 1001-1009 (1996).
8. M. Essig, G. Nguyen, D. Prie, et al., 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells: role of geranylgeranylation and Rho proteins, Circ. Res. 37, 683-690 (1998).
9. U. Laufs, K. Gertz, P. Huang, et al., Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice, Stroke 31, 2442-2449 (2000).
10. S. Wassmann, U. Laufs, A. T. Baumer, et al., HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species, Hypertension 37, 1450-7145 (2001).
11. S. I. McFarlane, R. Muniyappa, R. Francisco, et al., Clinical rewiew 145. Pleiotropic effects of statins: lipid reduction and beyond, J. Clin. Endocrinol. Metab. 87(4), 1451-1458 (2002).
12. F. Galli, F. Canestrari, and G. Bellomo, Pathophysiology of the oxidative stress and its implication in uremia and dialysis, in Vitamin E-Bonded Membrane. A Further Step in Dialysis Optimization, C. Ronco and G. La Greca (eds.), Contributions in Nephrology, Vol. 27, Karger, Basel, pp. 1-31 (1999).
13. J. Hopkins and G. R. Tudhope, Glutathione peroxidase in human red cells in health and disease, Br. J. Haematol. 25, 563-575 (1973).
14. J. Nève, Methods in determination of selenium states, J. Trace Elements Electrolytes Health Dis. 5, 1-17 (1991).
15. N. W. Alcock, Trace elements, in Clinical Chemistry, 3rd ed., L. A. Kaplan and A. J. Pesce (eds.), Mosby-Year Book, St. Louis, MO, p. 746 (1996).
16. J. Aaseth and T. Norsth, Copper, in Handbook on the Toxicology of Metals, L. Friberg, G. F. Nordberg, and V. B. Vouk (eds.), Elsevier, New York, Vol. H, pp. 233-249 (1986).
17. J. H. Kramer, T. Mak, and W. B. Weblicki, Differential sensitivity of canine cardiac sarcolemmal and microsomal enzymes to inhibition by free radical induced lipid peroxidation, Circ. Res. 55, 120-124 (1984).
18. S. U. Rajguru, G. S. Yeargans, and N. W. Seidler, Exercise causes oxidative damage to rat skeletal muscle microsomes while increasing cellular sulphydryls, Life Sci. 54, 149-157 (1993).
19. V. Nair, G. A. Turner, and R. J. Offerman, Novel adducts from the modification of nucleic acid bases by malondialdehyde, J. Am. Chem. Soc. 106, 3370-3371 (1984).
20. A. Aydin, H. Orhan, A. Sayal, et al., Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control, Clin. Biochem. 34, 65-70 (2001).
21. S. K. Jain, Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells, J. Biol. Chem. 264, 21,340-21,345 (1989).
22. S. Taddel, A. Virdis, L. Ghiadoni, et al., Effects of hypertensive drugs on endothelial dysfunction: clinical implications, Drugs 62(2), 265-284 (2002).
23. H. Sies, Oxidative stress: introductory remarks, in Oxidative Stress, H. Sies (ed.), Academic, Orlando, FL, p. 1 (1985).
24. M. N. Diaz, B. Frei, J. A. Vita, et al., Antioxidants and atherosclerotic heart disease, N. Engl. J. Med. 337, 408 (1997).
25. M. L. Kennedy, M. L. Failla, and J. C. Smith, Jr., Influence of genetic obesity on tissue concentrations of zinc, copper, manganese, and iron in mice, J. Nutr. 116, 1432-1441 (1986).
26. S. Delbosc, M. Morena, F. Djouad, et al., 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes, J. Cardiovasc. Pharmacol. 40(4), 611-617 (2002).
27. R. De Caterina, F. Cipollone, F. P. Filardo, et al., Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E, Circulation 106(20), 2543-2549 (2002).
28. J. Beltowski, G. Wojcicka, M. Mydlarczyk, et al., Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat, Pol. J. Pharmacol. 54(2), 143-150 (2002).
29. R. E. Wildman and S. Mao, Tissue-specific alterations in lipoprotein lipase activity in copper-deficient rats, Biol. Trace Element Res. 80(3), 221-229 (2001).
30. M. Fields and C. G. Lewis, Level of dietary iron, not type of dietary fat, is hyperlipidemic in copper-deficient rats, Am. Coll. Nutr. 18(4), 353-357 (1999).
31. D. J. Lamb, G. L. Reeves, A. Taylor, et al., Dietary copper supplementation reduces atherosclerosis in the cholesterol-fed rabbit, Atherosclerosis 146(1), 33-43 (1999).
32. A. E. Say, M. Gursurer, M. V. Yazicioglu, et al., Impact of body iron status on myocardial perfusion, left ventricular function, and angiographic morphologic features in patients with hypercholesterolemia, Am. Heart J. 143(2), 257-264 (2002).
33. R. G. Weginwar, S. Enomoto, R. Hirunuma, et al., Correlation between serum cholesterols and trace element uptake in liver, kidney, and blood of hypercholesterolemic mice, Biol. Trace Element Res. 86(3), 249-268 (2002).
34. J. Delattre, S. Lepage, M. C. Jaudon, et al., The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis, Ann. Pharm. Fr. 56(1), 18-25 (1998).